首页 | 本学科首页   官方微博 | 高级检索  
检索        

选择性COX-2抑制剂抑制肺癌生长的实验研究
引用本文:周丹,陈鸿义,刘桐林.选择性COX-2抑制剂抑制肺癌生长的实验研究[J].第四军医大学学报,2009(16):1472-1475.
作者姓名:周丹  陈鸿义  刘桐林
作者单位:武汉亚洲心脏病医院心胸外科;北京大学第一医院胸外科;
摘    要:目的:观察选择性环氧合酶-2(COX-2)抑制剂塞来昔布对肺癌A549细胞在体内外的抑制作用.方法:噻唑蓝(MTr)比色法检测塞来昔布对肺癌细胞的增殖抑制,流式细胞技术检测药物处理后A549的细胞周期,观察塞来昔布对裸鼠A549细胞移植瘤的抑制作用,移植瘤切片TUNEL法检测癌细胞凋亡.结果:塞来昔布对肺癌细胞增殖有抑制作用,IC50为500ummol/L;阻滞G1期细胞进入S期.称量裸鼠移植肿瘤的瘤结节质量,对照组(2.16±0.98)g,药物组(0.98±0.51)g,两组差异有统计学意义(P〈0.05),抑瘤率为54.6%.TUNEL法移植瘤切片凋亡细胞染色对照组凋亡指数(AI)为1.6±0.6,用药组为9.5±2.5,差异有统计学意义(P〈0.05).结论:塞来昔布在体内及体外均对肺癌细胞表现有抑制作用,将细胞周期阻滞在G1期并诱导肿瘤细胞凋亡可能是抑制肺癌细胞增殖的重要机制.

关 键 词:肺肿瘤  环氧合酶-2  塞来昔布  细胞周期  细胞凋亡

Experimental study on inhibitive effect of celecoxib on lung cancer
ZHOU Dan,CHEN Hong-Yi,LIU Tong-Lin.Experimental study on inhibitive effect of celecoxib on lung cancer[J].Journal of the Fourth Military Medical University,2009(16):1472-1475.
Authors:ZHOU Dan  CHEN Hong-Yi  LIU Tong-Lin
Institution:ZHOU Dan1,CHEN Hong-Yi2,LIU Tong-Lin2 1Department of Cardiac Surgery,Wuhan Asia Heart Hospital,Wuhan 430022,China,2Department of Thoracic Surgery,First Hospital of Peking University,Beijing 100034
Abstract:AIM:To observe the inhibitive effect of celecoxib,a selective inhibitor of cyclooxygenase-2(COX-2),in vitro and in vivo,on the proliferation of A549 cell line.METHODS:Antiproliferative effect was detected by MTT assay and flow cytometry was used to analyze the effect of celecoxib on cell cycles.Nude mice bearing lung cancer xenografts were treated with celecoxib and then the weight of implanted tumors was measured.The apoptotic cells in implanted tumors were stained by terminal deoxynucleotidyl transferasem...
Keywords:lung neoplasms  cyclooxygenase-2  celecoxib  cell cycle  apoptosis  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号